Wong Evan N, Mackey David A, Morgan William H, Chen Fred Kuanfu
Centre for Ophthalmology and Visual Science, (Lions Eye Institute), The University of Western Australia, Perth, WA, Australia.
Centre for Ophthalmology and Visual Science, (Lions Eye Institute), The University of Western Australia, Perth, WA, Australia; Department of Ophthalmology, Royal Perth Hospital, Perth, WA, Australia.
Clin Ophthalmol. 2015 Dec 23;10:29-42. doi: 10.2147/OPTH.S92018. eCollection 2016.
To investigate the intersession test-retest variability (TRV) of topography- and threshold-based parameters derived from the Nidek MP-1.
Prospective observational study.
Sixteen participants with and without central scotoma underwent microperimetry in one eye over three sessions at 1-month intervals in a single institution. We calculated 95% coefficient of repeatability (CR) for the number of normal-suspect (NS) loci, relative scotoma (RS) and dense scotoma (DS), median macular sensitivity (MS), mean sensitivity of responding loci (RLS), perilesional loci (PLS), and extralesional loci (ELS). Topographical agreement score of mapping NS and DS loci (TASNS and TASDS) were also calculated for each patient.
Mean (range) age was 50 (21-86) years. The CR (95% confidence intervals) for NS, RS, and DS were 9.9 (6.5-13.3), 9.5 (6.2-12.7), and 3.0 (1.1-4.1) respectively. CR (95% CIs) for median MS, mean RLS, PLS, and ELS were 3.4 (2.3-4.5), 1.6 (1.1-2.2), 1.8 (0.9-2.6), and 2.8 (1.5-4.0) dB. We found significant change in thresholds between Test 1, and Tests 2 and 3 (both P=0.03), but not between Tests 2 and 3 (P=0.8). Medians (range) TASNS and TASDS were 74% (39%-100%) and 77% (0%-97%), respectively, between Tests 2 and 3.
We recommend the use of four DS loci (upper limit of CR) as the limit of TRV for assessing change. There was large interindividual variability in NS or DS mapping agreement. We recommend discarding the first microperimetry test and caution the use of a change in spatial distribution to determine disease progression.
研究从尼德克MP - 1获得的基于地形图和阈值的参数在不同测量时段之间的重测变异性(TRV)。
前瞻性观察性研究。
16名有或无中心暗点的参与者在单一机构中,单眼接受了为期三个月、间隔1个月的微视野检查。我们计算了正常可疑(NS)位点数量、相对暗点(RS)和致密暗点(DS)、黄斑中值敏感度(MS)、反应位点平均敏感度(RLS)、病变周围位点(PLS)和病变外位点(ELS)的95%重复性系数(CR)。还为每位患者计算了绘制NS和DS位点的地形图一致性评分(TASNS和TASDS)。
平均(范围)年龄为50(21 - 86)岁。NS、RS和DS的CR(95%置信区间)分别为9.9(6.5 - 13.3)、9.5(6.2 - 12.7)和3.0(1.1 - 4.1)。黄斑中值MS、平均RLS、PLS和ELS的CR(95%置信区间)分别为3.4(2.3 - 4.5)dB、1.6(1.1 - 2.2)dB、1.8(0.9 - 2.6)dB和2.8(1.5 - 4.0)dB。我们发现第1次测试与第2次和第3次测试之间阈值有显著变化(均P = 0.03),但第2次和第3次测试之间无显著变化(P = 0.8)。第2次和第3次测试之间,TASNS和TASDS的中位数(范围)分别为74%(39% - 100%)和77%(0% - 97%)。
我们建议使用四个DS位点(CR上限)作为评估变化的TRV界限。NS或DS绘图一致性存在较大个体间变异性。我们建议舍弃第一次微视野检查,并谨慎使用空间分布变化来确定疾病进展。